peoplePerson
Shaoli Song
Leads the nuclear medicine group behind the first human TROP2 PET imaging, aiming to pick patients for TROP2 ADCs with a scan.
Shaoli Song's department at FUSCC developed and imaged the first TROP2-targeted PET tracers in patients with breast and other cancers, alongside FAPI, HER2, and PSMA theranostic work.
Role
Professor and Director, Department of Nuclear Medicine, Fudan University Shanghai Cancer Center
Institution
Specialisms
Nuclear medicinePET tracer developmentTROP2 and HER2 PETTheranostics
Pages like this
not linked directly; found by shared links- PersonYi-Zhou Jiang
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
- IdeaAlpha radioligands after ADC failure
Shares TROP2 PET, TROP2, Triple-negative breast cancer (TNBC).
- PairingTROP2 PET → TROP2 ADC selection
Shares TROP2 PET, TROP2, Triple-negative breast cancer (TNBC).
- PersonFrederik Giesel
- PersonXichun Hu
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).
- TechnologyCAR-T against stroma: fibroblasts and myeloid cells
- RoadmapMolecular imaging roadmap: FDG → PSMA → FAP → antigen and immune PET
- PersonZhi-Ming Shao
Shares Fudan University Shanghai Cancer Center, Triple-negative breast cancer (TNBC).